Brief: Prostatype Signs Deal With Cambridge Clinical Laboratories
17/08/2021 14:02
Aug 17 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* PROSTATYPE GENOMICS SIGNS AGREEMENT WITH CAMBRIDGE
CLINICAL
LABORATORIES, CCL
* THIS COOPERATION FURTHERS PROSTATYPE'S ENTRY INTO ANOTHER
PRIORITIZED MARKET, IN LINE WITH COMPANY'S STRATEGY.
Source text for Eikon: ID:nWkr7BfqzJ
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln
Brief: Prostatype Genomics Intends To Resolve On Rights Issue
Brief: Prostatype Genomics Reports H2 EBITDA Of SEK -17.8 Mln
Brief: Prostatype Genomics Signs Loan Financing Of SEK 10 Million
Brief: Prostatype Genomics Gets SEK 11.5 Mln Through Exercise Of Warrants